Hyperhidrosis affects people of all ages, genders, and nationalities, but not to the same extent. Genetic and environmental factors affect some populations more than others.
The prevalence of hyperhidrosis has been studied around the world to collect data on populations in Canada, the United States, France, Brazil, and Korea. What does the study say about the effects of environment on hyperhidrosis and how does it affect populations differently?
The United States
The largest study was done in the United States using 7,772,850 participants.
Dr. David Strutton found that hyperhidrosis was prevalent in 2.8% of their survey population. For more than half of them, excessive sweating of the hands and feet was the most common. That's almost 5 million people in the US alone.
The highest prevalence rates were seen in the 25 and 65-year-old age groups and the lowest seen in those under 12 years of age. There were no significant differences between genders.
Perhaps the most shocking statistic in this study is only 38% of participants had consulted their physician about excessive sweating.
Elsewhere in the world.
In the Asian population, there is an unusually large amount of people suffering from palmar (hand) hyperhidrosis with up to a 5% of people suffering from hyperhidrosis in certain areas of China.
In Brazil’s hot and humid climate, one study suggests that up to 9% of people suffer from hyperhidrosis.
Those suffering from hyperhidrosis sometimes search for years looking for a solution to their sweating. The frustration of trying to find a treatment combined with the adaptations one needs to make to their everyday lives can lead those who suffer from hyperhidrosis to become depressed.
As doctors begin to recognize hyperhidrosis as a condition, new treatment methods are being pioneered. Iontophoresis has proven to be one of the most successful treatment methods. Our iD-1000 has a 98% success rate. Our device, crafted using top of the line materials and tried, tested and true manufacturing procedures combines the most effective treatment with an affordable price tag.
Want to learn more? Check out these studies:
Liked this article? You might also like: